Shalender Bhasin, MD
Endocrinology, Diabetes & Metabolism · Weston, MANPI 1134138274
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $18,050 of the $27,449 with a category attached, or 65.8%. Besins Healthcare Ireland Limited accounts for 85.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $23,500 and has fallen 83.9% since, to $3,788 in 2024.
Across 16 payments — averaging $1715.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Besins Healthcare Ireland Limited$23K
- Eli Lilly$4K
- Novo Nordisk$161
Across 9 payments — averaging $28,181 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$253K
- AbbVie$765
What the payments were for
- Consulting fees$9,23834%
- Travel & lodging$18,05066%
- Education$1611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Besins Healthcare Ireland Limited | 6 | $23,500 |
| Eli Lilly | 5 | $3,788 |
| Novo Nordisk | 5 | $161 |
How this compares
$27,449 in reported general payments places this provider in the 85th percentile of 360 endocrinology, diabetes & metabolism providers in Massachusetts.
See all endocrinology, diabetes & metabolism providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 98 | $3,307 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Weston
- Jason GagliaBoston$2.4M
- Tamer YacoubFall River$775K
- Vanita ArodaBoston$482K
- Michael RosenblattBoston$447K
- Steven RussellBoston$445K
- Nitin TrivediWorcester$403K
- Beverly BillerBoston$346K
- Christos MantzorosBoston$243K
- Peter ButlerFlorence$216K
- Augusto Caballero-RoblesBoston$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.